
View larger version (73K):
[in a new window]
|
Fig. 4. Zen binding is enhanced in the presence of Mad. (A) Schematic
representation of the 42 bp wild-type (wt-42) and mutant oligonucleotides that
eliminate the core Smad-(Sm-42) or Zen-(Zm-42) binding sites, and the 128 bp
DNA fragment from the Race enhancer used in electrophoretic mobility
shift assays (EMSAs) showing Medea-(blue circle), Mad-(blue ovals) and
Zen-(red ovals) binding sites. (B) DNA binding requires the core consensus
sites. 32P-labeled wild type (lanes 1-4) and mutant
oligonucleotides (Sm-42, lanes 5-8; Zm-42, lanes 9-12) were incubated with no
protein (lanes 1,5,9); and 100 ng Mad (lanes 2,6,10), 100 ng Medea (lanes
3,7,11) or 10 ng Zen (lanes 4,8,12). Mad and Medea produce a single complex of
bound probe, whereas Zen produces two complexes. The slower migrating Zen
complex could be due to a Zen/Zen/DNA complex. Mutant Sm-42 (or Zm-42)
eliminated the binding of Mad/Medea (or Zen) without affecting the binding of
Zen (or Mad/Medea). (C) 32P-labeled wild-type DNA fragments were
incubated with no protein (lanes 1 and 5), increasing amounts of Mad (1 ng, 2
ng, and 5 ng in lanes 2-4, respectively), increasing amounts of Zen (0.1 ng,
0.3 ng, and 1 ng in lanes 6-9, respectively) or increasing amounts of Zen in
the presence of 1 ng of Mad (lanes 10-13). The amounts of Zen in lanes 10-13
were the same as in lanes 6-9. More Zen complexes are shifted in lanes 10-13
compared with lanes 6-9. In lane 13, a supershifted complex (arrow) is visible
above the Zen complex (arrowhead) that may be due to the formation of a
Mad/Zen/DNA complex or a Zen/Zen/DNA complex. (D) Similar experiment as in C,
except that Zen-Del was used instead of wild-type Zen. The same amounts of
proteins were used as in C. Enhancement of Zen binding by Mad was not
observed.
|